Deletion of ENO1 sensitizes pancreatic cancer cells to gemcitabine via MYC/RRM1-mediated glycolysis. - Lu Y; Ma H; Xiong X; Du Y; Liu L; Wang J; Zhao W (Scientific reports, 2025)